Related Experiment Videos
Corticosteroid therapy and chronic obstructive pulmonary disease.
1Respiratory Care Services, Duke University Medical Center, Durham, North Carolina 27710, USA. neil.macintyre@duke.edu
Respiratory Care
|March 15, 2006
Summary
Inhaled corticosteroids can prevent exacerbations in chronic obstructive pulmonary disease (COPD). Oral corticosteroids help reduce the severity and duration of COPD exacerbations, with fewer side effects when inhaled.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) involves chronic airway inflammation from irritants like tobacco smoke.
- Acute exacerbations, often infectious, punctuate the disease course.
- COPD inflammation differs from asthma but may respond to corticosteroids, particularly in certain patient subgroups and during exacerbations.
Purpose of the Study:
- To evaluate the role of corticosteroid therapy in managing chronic obstructive pulmonary disease (COPD).
- To assess the efficacy of inhaled and oral corticosteroids in preventing and treating COPD exacerbations.
Main Methods:
- Review of clinical evidence supporting corticosteroid use in COPD.
- Analysis of the benefits of inhaled versus oral corticosteroid administration.
Main Results:
- Inhaled corticosteroids are effective in preventing COPD exacerbations.
- Oral corticosteroids significantly reduce the duration and impact of COPD exacerbations.
- Inhaled corticosteroid use is associated with fewer complications compared to long-term oral use.
Conclusions:
- Corticosteroids, particularly inhaled forms, are a valuable therapeutic option for managing COPD.
- Inhaled corticosteroids are recommended for exacerbation prevention in COPD.
- Oral corticosteroids provide benefits during acute exacerbations of COPD.